Investor
Relations

 

 

 

 

 

CSE:VLAB

Building the leading global peptide and longevity brand.

Vesalius Longevity Labs (CSE: VLAB) is a longevity and regenerative health platform focused on peptides, biologics and preventative healthcare. Vesalius’ proprietary ecosystem is designed to connect healthcare providers with trusted, compliant pharmacies and support the people they serve with access to quality therapies, education, and partnerships.

Through its announced collaboration with Celularity, the Company is developing a U.S. final-stage manufacturing and supply platform for its Peptual®-branded peptide APIs (active pharmaceutical ingredients) for domestic and international compounding supply chains in accordance with local laws and regulations. Vesalius’s vision is to deliver on the promise of longevity by enabling the future of personalized health and wellness.

Company Snapshot

US$6.8T

Global Wellness Economy
7.3% projected annual growth, 2023–2028¹

US$7.9M

9 Month Revenue
(Period Ended July 31, 2026)

~44%

Blended Margin
(Period Ended July 31, 2026)

5

Key Revenue Streams
Peptual®, Pens, Telemedicine, API/Pharmacy, Biologics/Regenerative MCI Collaboration

Latest News

Latest Presentation